REG - Hikma Pharmaceutical - Director/PDMR Shareholding

Hikma PharmaceuticalsAnnouncement

22/08/2018 09:45

RNS Number : 5563Y
Hikma Pharmaceuticals Plc
22 August 2018
 


Notification and public disclosure of transactions by persons discharging managerial responsibilities
 



1


Details of the person discharging managerial responsibilities / person closely associated




a)


Name


Bassam Kanaan




2


Reason for the notification




a)


Position/status


Chief Strategy and Corporate Development Officer




b)


Initial notification /Amendment


Initial notification




3


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name


Hikma Pharmaceuticals PLC




b)


LEI


549300BNS685UXH4JI75




4


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a)


Description of the financial instrument, type of instrument and identification code


Description: Ordinary shares of 10 pence each
ID Code: GB00B0LCW083




b)


Nature of the transaction
 


Disposal of 30,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC.




c)


Price(s) and volume(s)


Price(s): £19.17
Volume(s): 30,000




d)


Aggregated information


Aggregated volume: 30,000
Price: £575,100




e)


Date of the transaction


20 to 21 August 2018




f)


Place of the transaction


London Stock Exchange (XLON)



Peter Speirs, Company Secretary, Responsible for releasing this announcement
22 August 2018




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHGIGDICXDBGID